Skip to results

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 51 to 75 of 132

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
icobrain ms for active relapsing–remitting multiple sclerosisMIB291
Integrated health and social care for people experiencing homelessnessNG214
Intramedullary distraction for lower limb lengtheningIPG718
Intramedullary distraction for upper limb lengtheningIPG722
Joint replacement (primary): hip, knee and shoulderQS206
Lenalidomide for relapsed or refractory mantle cell lymphoma (terminated appraisal)TA774
Liposuction for chronic lipoedemaIPG721
Liposuction for chronic lymphoedemaIPG723
Liraglutide for managing obesity in people aged 12 to 17 years (terminated appraisal)TA749
Lumella point-of-care test for assessing pre-eclampsia riskMIB287
Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adultsNG215
Mental wellbeing at workNG212
Mexiletine for treating the symptoms of myotonia in non-dystrophic myotonic disordersTA748
Microwave ablation for primary or metastatic cancer in the lungIPG716
Mogamulizumab for previously treated mycosis fungoides and Sézary syndromeTA754
Multiple sclerosis in adults: managementNG220
myCOPD for managing chronic obstructive pulmonary diseaseMTG68
Neonatal parenteral nutritionQS205
Nerve graft for corneal denervationIPG729
Niraparib for maintenance treatment of relapsed, platinum-sensitive ovarian, fallopian tube and peritoneal cancerTA784
Nivolumab with cabozantinib for untreated advanced renal cell carcinoma (terminated appraisal)TA785
Nivolumab with ipilimumab for untreated advanced renal cell carcinomaTA780
Odevixibat for treating progressive familial intrahepatic cholestasisHST17
Olaparib for maintenance treatment of BRCA mutation-positive metastatic pancreatic cancer after platinum-based chemotherapy (terminated appraisal)TA750
Olaparib for treating BRCA mutation-positive HER2-negative metastatic breast cancer after chemotherapy (terminated appraisal)TA762

Results per page

  1. 10
  2. 25
  3. 50
  4. All